Search Within

David Randolph Jones

  1. "Molecular Pharmacology and Chemistry Program Faculty"
Formats
  1. Journal Article (9)
  2. Meeting Abstract (8)
Groups
  1. Department of Medicine (17)
  2. Molecular Pharmacology and Chemistry Program Faculty (17)
  3. Sloan Kettering Institute Faculty (17)
  4. Surgery (17)
  5. GSK Faculty (15)
  6. Hematologic Malignancies, Division of (15)

More Groups

People
  1. Prasad Adusumilli (14)
  2. Michel Sadelain (11)
  3. Aurore Morello (6)
  4. Valerie Rusch (6)
  5. Jonathan Villena-Vargas (5)
  6. Kay See Tan (4)

More People

Years
  1. 2021 (2)
  2. 2020 (1)
  3. 2019 (2)
  4. 2018 (1)
  5. 2017 (3)
  6. 2016 (2)

More Years

Publications
  1. Journal of Thoracic Oncology (6)
  2. Cancer Discovery (3)
  3. Annals of Thoracic Surgery (1)
  4. Cancer Research (1)
  5. Clinical Cancer Research (1)
  6. Journal of Clinical Investigation (1)

More Publications

Publishers
  1. Elsevier Inc. (6)
  2. American Association for Cancer Research (5)
  3. Elsevier Science, Inc. (2)
  4. American Association for the Advancement of Science (1)
  5. American Society for Clinical Investigation (1)
  6. American Society of Clinical Oncology (1)

More Publishers

Results (17)

Export to EndNote / Excel | PubMed

Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Preoperative chemoprophylaxis is safe in major oncology operations and effective at preventing venous thromboembolism
    Journal Article

    Selby, L. V.; Sovel, M.; Sjoberg, D. D.; McSweeney, M.; Douglas, D.; Jones, D. R.; Scardino, P. T.; Soff, G. A.; Fabbri, N.; Sepkowitz, K.; more...
    Journal of the American College of Surgeons (2016)

    Fulltext@MSK | Save
  • Targetable cancer-associated antigens for immunotherapy in malignant pleural mesothelioma (MPM) — Mesothelin, CA125 and WT-1
    Meeting Abstract

    Ujiie, H.; Eguchi, T.; Mayor, M.; Kadota, K.; Travis, W. D.; Jones, D. R.; Sadelain, M.; Adusumilli, P. S.
    Journal of Thoracic Oncology (2015)

    Fulltext@MSK | Save
  • Genetic-engineering strategies to enhance CAR T-cell therapy efficacy against PD-L1 expressing lung adenocarcinoma and mesothelioma
    Meeting Abstract

    Cherkassky, L.; Morello, A.; Villena-Vargas, J.; Mayor, M.; Jones, D. R.; Sadelain, M.; Adusumilli, P. S.
    Journal of Thoracic Oncology (2015)

    Fulltext@MSK | Save
  • Mesothelin-targeted CAR T-cell therapy for the treatment of heterogeneous antigen-expressing lung adenocarcinoma
    Meeting Abstract

    Morello, A.; Villena-Vargas, J.; Mayor, M.; Bograd, A. J.; Jones, D. R.; Sadelain, M.; Adusumilli, P. S.
    Journal of Thoracic Oncology (2015)

    Fulltext@MSK | Save
  • Tumor-targeted radiation therapy helps overcome the solid tumor T-cell infiltration barrier and promotes mesothelin CAR T-cell therapy
    Meeting Abstract

    Mayor, M.; Villena-Vargas, J.; De Biasi, A.; Morello, A.; Jones, D. R.; Sadelain, M.; Adusumilli, P. S.
    Journal of Thoracic Oncology (2015)

    Fulltext@MSK | Save
  • Mesothelin and MUC16 (CA125) are antigen-targets for CAR T-cell therapy in primary and metastatic lung adenocarcinoma
    Meeting Abstract

    Eguchi, T.; Ujiie, H.; Morello, A.; Kadota, K.; Buitrago, D. H.; Woo, K.; Jones, D. R.; Travis, W. D.; Sadelain, M.; Adusumilli, P. S.
    Journal of Thoracic Oncology (2015)

    Fulltext@MSK | Save
  • Regional delivery of mesothelin-targeted CAR T cell therapy generates potent and long-lasting CD4-dependent tumor immunity
    Journal Article

    Adusumilli, P. S.; Cherkassky, L.; Villena-Vargas, J.; Colovos, C.; Servais, E.; Plotkin, J.; Jones, D. R.; Sadelain, M.
    Science Translational Medicine (2014)

    Fulltext@MSK | Save